This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Medika Talks with Serial Health Tech Entrepreneur Jay Schiff About His Efforts to Unite Devices with Digital Health to Offer a New Pathway to Patient Care

We are setting ourselves up for bitter disappointment when AI is unable to deliver a future that was over-promised.

While the fax may be the safest way to keep physicians HIPAA compliant, it creates a behavior inconsistent with their chosen mission — to save lives.